Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities.
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Activated microglia enhance neurogenesis via trypsinogen secretion.
Anorexia heralding the onset of neuromyelitis optica.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Acquired channelopathies as contributors to development and progression of multiple sclerosis.
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis.
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Sleep and oligodendrocyte functions.
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis.
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Association of Missense Mutations of Mediterranean Fever (MEFV) Gene with Multiple Sclerosis in Turkish Population.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Uveitis as a prognostic factor in multiple sclerosis.
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Multiple sclerosis and seizures: incidence and prevalence over 40 years.
Daclizumab for relapsing remitting multiple sclerosis.
Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data.
Immune modulation by a tolerogenic MOG10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
PLZF Regulates CCR6 and Is Critical for the Acquisition and Maintenance of the Th17 Phenotype in Human Cells.
Rare Inflammatory Diseases of the White Matter and Mimics of Multiple Sclerosis and Related Disorders.
Pages
« first
‹ previous
…
265
266
267
268
269
270
271
272
273
…
next ›
last »